EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days

Yu-Ming Ding, Miao Duan, Zhong-Xue Han, Xiao-Hui Song, Feng-Lan Zhang, Zhi Wang, Zhang Ning, Shu-Yan Zeng, Qing-Zhou Kong, Wen-Lin Zhang, Jing Liu, Meng Wan und 7 weitere

Digestive Diseases and Sciences · 2024

DOI: 10.1007/s10620-024-08460-3 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Digestive Diseases and Sciences, 2024. Verfasst von Yu-Ming Ding und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, No. 107, Wenhuaxi Road, Jinan, 250012, Shandong, Chi…. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Drug Therapy, Combination, Tetracycline. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Clinical Research Center for Digestive Diseases supporting technology project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriDrug Therapy, CombinationTetracyclineAnti-Bacterial AgentsBismuthClarithromycinAmoxicillinSulfonamidesDrug Administration ScheduleHumansMiddle AgedMaleFemaleAdultPyrrolesProton Pump InhibitorsBreath TestsTreatment OutcomeAgedChina

Stichwörter der Autor:innen

Helicobacter pyloriAntibioticDurationGastric cancer

Substanzen

TetracyclineAnti-Bacterial AgentsBismuthClarithromycinAmoxicillinSulfonamides1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanaminePyrrolesProton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, No. 107, Wenhuaxi Road, Jinan, 250012, Shandong, China.
  • Laboratory of Translational Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
  • Shandong Provincial Clinical Research Center for Digestive Disease, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • The People's Hospital of Jimo., Qingdao, Shandong, China.
  • Heze Municipal 3rd People's Hospital, Heze, Shandong, China.
  • Maternity and Child Care Health Center of Dezhou, Dezhou, Shandong, China.

Förderung

  • National Natural Science Foundation of China
  • National Clinical Research Center for Digestive Diseases supporting technology project

Zitieren

APA

Ding, Y. M., Duan, M., Han, Z. X., Song, X. H., Zhang, F. L., Wang, Z., Ning, Z., Zeng, S. Y., Kong, Q. Z., Zhang, W. L., Liu, J., Wan, M., Lin, M. J., Lin, B. S., Nan, X. P., Wang, H., Li, Y. Y., Zuo, X. L., & Li, Y. Q. (2024). Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08460-3

Vancouver

Ding YM, Duan M, Han ZX, Song XH, Zhang FL, Wang Z, et al. Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days. Digestive Diseases and Sciences. 2024. doi:10.1007/s10620-024-08460-3

BibTeX
@article{Ding2024,
  author = {Ding, Yu-Ming and Duan, Miao and Han, Zhong-Xue and Song, Xiao-Hui and Zhang, Feng-Lan and Wang, Zhi and Ning, Zhang and Zeng, Shu-Yan and Kong, Qing-Zhou and Zhang, Wen-Lin and Liu, Jing and Wan, Meng and Lin, Min-Juan and Lin, Bo-Shen and Nan, Xue-Ping and Wang, Hui and Li, Yue-Yue and Zuo, Xiu-Li and Li, Yan-Qing},
  title = {Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days},
  journal = {Digestive Diseases and Sciences},
  year = {2024},
  doi = {10.1007/s10620-024-08460-3}
}
Kostenlos starten →